POSTS: Contrast dye shortage: Avoid CT scan requests ‘wherever feasible’, specialists urged

Medicines

Some AML patients can safely come off venetoclax-based therapy after achieving remission, study suggests

Blood cancers

EHA 2022 – Game Changers for Australian haematologists

Haematology centre staff show ‘implicit bias’ in racial survey

Medicopolitical

‘Outdated’ PBS rules on inpatient chemo jeopardise access to high-cost leukaemia therapies

Blood cancers

Ceiling effect limits effect of COVID booster in prior ‘high responders’

Public health

MORE NEWS

News in brief: Five Australian domestic plasma products to change; Long COVID thrombosis risk link to exercise capacity; Clues to how to best use fourth COVID-19 booster

Ditch the Hodgkin definition of lymphomas, haematologists argue

Blood cancers

Specialist trainees ‘limiting family size’ to fit program rules

COVID-19

HSANZ releases COVID-19 treatment advice for patients with blood cancers

Blood cancers

News in brief: DOACs don’t drive epistaxis admissions; Anakinra may prevent intestinal injury in blood cancer patients; Medical acronyms mystify patients

Amyloidosis patients could benefit from early switch to second-line therapy: study

Research

NZ Medical Association faces collapse due to plummeting membership

Rural vs city doctors: Who has had the most stressful pandemic?

Doctors health

Blood cancer patients have highest COVID risk: review

HSCT potential for children with severe autoimmune diseases: review

Research

Clinical spectrum of VITT can include arterial thrombosis presenting as stroke

Coagulation

News in brief: Overcoming venetoclax resistance in AML; 3 ways to reduce carbon footprint from diagnostic imaging; ASCOT ends anticoagulation treatment arm for COVID-19

more news

SEARCH

CATEGORIES

About

Search

Account

Saved

SEARCH

CATEGORIES

POSTS: Contrast dye shortage: Avoid CT scan requests ‘wherever feasible’, specialists urged

Medicines

Some AML patients can safely come off venetoclax-based therapy after achieving remission, study suggests

Blood cancers

EHA 2022 – Game Changers for Australian haematologists

Haematology centre staff show ‘implicit bias’ in racial survey

Medicopolitical

‘Outdated’ PBS rules on inpatient chemo jeopardise access to high-cost leukaemia therapies

Blood cancers

Ceiling effect limits effect of COVID booster in prior ‘high responders’

Public health

MORE NEWS

News in brief: Five Australian domestic plasma products to change; Long COVID thrombosis risk link to exercise capacity; Clues to how to best use fourth COVID-19 booster

Ditch the Hodgkin definition of lymphomas, haematologists argue

Blood cancers

Specialist trainees ‘limiting family size’ to fit program rules

COVID-19

HSANZ releases COVID-19 treatment advice for patients with blood cancers

Blood cancers

News in brief: DOACs don’t drive epistaxis admissions; Anakinra may prevent intestinal injury in blood cancer patients; Medical acronyms mystify patients

Amyloidosis patients could benefit from early switch to second-line therapy: study

Research

NZ Medical Association faces collapse due to plummeting membership

Rural vs city doctors: Who has had the most stressful pandemic?

Doctors health

Blood cancer patients have highest COVID risk: review

HSCT potential for children with severe autoimmune diseases: review

Research

Clinical spectrum of VITT can include arterial thrombosis presenting as stroke

Coagulation

News in brief: Overcoming venetoclax resistance in AML; 3 ways to reduce carbon footprint from diagnostic imaging; ASCOT ends anticoagulation treatment arm for COVID-19

Log in

SEARCH

CATEGORIES

About

Search

Account

Saved

SEARCH

CATEGORIES

POSTS: Contrast dye shortage: Avoid CT scan requests ‘wherever feasible’, specialists urged

Medicines

Some AML patients can safely come off venetoclax-based therapy after achieving remission, study suggests

Blood cancers

EHA 2022 – Game Changers for Australian haematologists

Haematology centre staff show ‘implicit bias’ in racial survey

Medicopolitical

‘Outdated’ PBS rules on inpatient chemo jeopardise access to high-cost leukaemia therapies

Blood cancers

Ceiling effect limits effect of COVID booster in prior ‘high responders’

Public health

MORE NEWS

News in brief: Five Australian domestic plasma products to change; Long COVID thrombosis risk link to exercise capacity; Clues to how to best use fourth COVID-19 booster

Ditch the Hodgkin definition of lymphomas, haematologists argue

Blood cancers

Specialist trainees ‘limiting family size’ to fit program rules

COVID-19

HSANZ releases COVID-19 treatment advice for patients with blood cancers

Blood cancers

News in brief: DOACs don’t drive epistaxis admissions; Anakinra may prevent intestinal injury in blood cancer patients; Medical acronyms mystify patients

Amyloidosis patients could benefit from early switch to second-line therapy: study

Research

NZ Medical Association faces collapse due to plummeting membership

Rural vs city doctors: Who has had the most stressful pandemic?

Doctors health

Blood cancer patients have highest COVID risk: review

HSCT potential for children with severe autoimmune diseases: review

Research

Clinical spectrum of VITT can include arterial thrombosis presenting as stroke

Coagulation

News in brief: Overcoming venetoclax resistance in AML; 3 ways to reduce carbon footprint from diagnostic imaging; ASCOT ends anticoagulation treatment arm for COVID-19